In a surprising move, Rentschler Biopharma announced its decision to withdraw from the cell and gene therapy (CGT) business at its Stevenage, UK facility, marking a significant shift in the company's strategic focus. This decision comes despite recent investments in building advanced capabilities
The recent moves by the Trump administration have cast a shadow of uncertainty over the biopharma sector, causing significant turmoil among companies relying on federal grants for clinical trials and drug development. The Office of Management and Budget (OMB) issued a memo on Monday that threatened
In a significant development in avian flu research, scientists from the University of Pittsburgh and the NIH Vaccine Research Center have crafted an innovative antibody therapy aimed at tackling the severe H5N1 avian flu virus in monkeys. This new therapy focuses on a broadly neutralizing antibody,
A recent study published in the American Society of Hematology's journal, Blood, has dispelled the long-held belief that sickle cell trait (SCT) can lead to sudden death, particularly under conditions of physical exertion. This misconception has disproportionately affected Black males with SCT,
A recent study conducted by researchers at NYU Langone Health has reexamined the purported link between a mother’s health during pregnancy and the likelihood of her child developing autism. This study disputes previous assertions that maternal health conditions during pregnancy contribute directly
On Thursday, the Food and Drug Administration approved Journavx, a highly anticipated non-opioid pain medication developed by Vertex Pharmaceuticals, marking a significant milestone in the effort to shift pain treatment away from opioids. This new drug has been initially approved to treat acute
